Potentiation of chloroform-induced hepatotoxicity by methyl isobutyl ketone and two metabolites. 1990

M Vézina, and A B Kobusch, and P du Souich, and E Greselin, and G L Plaa
Département de pharmacologie, Faculté de médecine, Université de Montréal, Québec, Canada.

The hepatonecrogenic properties of chloroform (CHCl3) can be modified by the administration of various chemicals. The ability of methyl isobutyl ketone (MIBK) and its two major metabolites, 4-methyl-2-pentanol (4MPOL) and 4-hydroxymethyl isobutyl ketone (4-OHMIBK) to potentiate the liver injury induced by CHCl3 was assessed in rats. The parent compound and both metabolites significantly increased the liver damage induced by CHCl3, as demonstrated by the elevation of the plasma activity of two transferases alanine aminotransferase and ornithine carbamoyl transferase and by the severity of the morphological changes. Moreover, the minimally effective dosage needed to potentiate CHCl3-induced hepatotoxicity was approximately 5 mmol/kg for the three compounds. We also studied the inducing properties of MIBK (cytochrome P-450 liver content and the activity of aniline hydroxylase, 7-ethoxycoumarin O-deethylase, and aminopyrine N-demethylase). Cytochrome P-450 content and the oxidation of aniline and 7-ethoxycoumarin were significantly increased with either a single (7.5 mmol/kg or greater) or a multiple (5.0 and 7.5 mmol.kg-1.day-1 for 5 days) administration of MIBK. An increase in the activity of the aminopyrine demethylase was also elicited by the repetitive administration of MIBK. With gel electrophoresis, we found that MIBK significantly increased the 52.1- and 54.1-kDa proteins, corresponding most probably to P-450 isozymes.

UI MeSH Term Description Entries
D007659 Ketones Organic compounds containing a carbonyl group Ketone
D008297 Male Males
D008742 Methyl n-Butyl Ketone An industrial solvent which causes nervous system degeneration. MBK is an acronym often used to refer to it. 2-Hexanone,Butylmethyl Ketone,Hexan-2-one,2 Hexanone,Hexan 2 one,Ketone, Butylmethyl,Ketone, Methyl n-Butyl,Methyl n Butyl Ketone,n-Butyl Ketone, Methyl
D008862 Microsomes, Liver Closed vesicles of fragmented endoplasmic reticulum created when liver cells or tissue are disrupted by homogenization. They may be smooth or rough. Liver Microsomes,Liver Microsome,Microsome, Liver
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D002725 Chloroform A commonly used laboratory solvent. It was previously used as an anesthetic, but was banned from use in the U.S. due to its suspected carcinogenicity. Trichloromethane
D002779 Cholestasis Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS). Bile Duct Obstruction,Biliary Stasis,Bile Duct Obstructions,Biliary Stases,Cholestases,Duct Obstruction, Bile,Duct Obstructions, Bile,Obstruction, Bile Duct,Obstructions, Bile Duct,Stases, Biliary,Stasis, Biliary
D003720 Densitometry The measurement of the density of a material by measuring the amount of light or radiation passing through (or absorbed by) the material. Densitometries
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug

Related Publications

M Vézina, and A B Kobusch, and P du Souich, and E Greselin, and G L Plaa
June 1992, Toxicology letters,
M Vézina, and A B Kobusch, and P du Souich, and E Greselin, and G L Plaa
September 1985, Toxicology and applied pharmacology,
M Vézina, and A B Kobusch, and P du Souich, and E Greselin, and G L Plaa
December 1981, Toxicology and applied pharmacology,
M Vézina, and A B Kobusch, and P du Souich, and E Greselin, and G L Plaa
March 1988, Toxicology and applied pharmacology,
M Vézina, and A B Kobusch, and P du Souich, and E Greselin, and G L Plaa
February 1994, Toxicology letters,
M Vézina, and A B Kobusch, and P du Souich, and E Greselin, and G L Plaa
December 1993, Environmental health perspectives,
M Vézina, and A B Kobusch, and P du Souich, and E Greselin, and G L Plaa
May 1976, Journal of neuropathology and experimental neurology,
M Vézina, and A B Kobusch, and P du Souich, and E Greselin, and G L Plaa
December 1987, Toxicology and applied pharmacology,
M Vézina, and A B Kobusch, and P du Souich, and E Greselin, and G L Plaa
January 1995, Toxicology letters,
Copied contents to your clipboard!